Vinci Gets EUR300 Million France-Spain Power-Exchange Contract
By Joshua Kirby
Vinci said Thursday that a consortium including two of its businesses won a contract for an electrical interconnection between France and Spain that will bring them some 300 million euros ($325.1 million.)
The contract to build two electrical energy converter stations was won by a consortium comprising Vinci Energies, Vinci Construction and Hitachi Energy, the French conglomerate said.
The stations will transform alternative current into direct current, and will be connected via an undersea cable between the two countries, enabling energy exchange between them, Vinci said.
The two Vinci businesses will be paid around EUR300 million for the design and construction of the stations, which should be delivered in 2028, the company said. The contract was awarded by Electricity Interconnection France-Spain, a joint venture bringing together the two countries' respective electricity-network operators.
Write to Joshua Kirby at joshua.kirby@wsj.com; @joshualeokirby
(END) Dow Jones Newswires
June 15, 2023 03:16 ET (07:16 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track